Nurse Practitioner, Family · Houston, TX
NPI
1538713599
Since 2019
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
1515 Holcombe Blvd
Houston, TX, 77030
Phone (713) 792-6161
Groups this clinician bills Medicare through
Medicare paid, 2024
$10K
271 services
Medicare patients, 2024
167
Average age 74
Drug cost, 2024
$2.6M
660 prescriptions
Company payments, 2025
$1,315
From 13 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Aji Mathew was code 99213 (office e&m - established), 123 times for 84 patients. In total Aji Mathew billed 271 services in 9 codes, and Medicare paid $10K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-07-29.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Facility | 123 | 84 | $41.39 | $5,091 |
| 99212 Office E&M - Established | Facility | 48 | 27 | $24.00 | $1,152 |
| 38222 Other Organ Systems | Facility | 46 | 44 | $48.23 | $2,219 |
| 99441 Telephone Services | Facility | 38 | 22 | $23.68 | $900 |
By year: 2022 $13K for 329 services; 2023 $10K for 297 services; 2024 $10K for 271 services.
Medicare prescription drug claims, 2024
In 2024, the drug Aji Mathew prescribed most often to Medicare patients was Imatinib Mesylate, with 64 prescriptions and refills. In total Aji Mathew wrote 660 Medicare prescriptions that cost $2.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Imatinib Mesylate Generic | 64 | 74 | Under 11 | $132K |
| Valacyclovir Valacyclovir Hcl | 47 | 79 | 16 | $1,171 |
| Levofloxacin Generic | 42 | 48 | 11 | $851 |
| Scemblix Asciminib Hydrochloride | 36 | 38 | Under 11 | $734K |
| Ondansetron Hcl Generic | 32 | 32 | Under 11 | $241 |
| Sprycel Dasatinib | 30 | 36 | Under 11 | $257K |
| Posaconazole Generic | 26 | 26 | Under 11 | $21K |
| Bosulif Bosutinib | 24 | 24 | Under 11 | $367K |
| Gleevec Imatinib Mesylate | 24 | 24 | Under 11 | $264K |
| Inqovi Decitabine/Cedazuridine | 21 | 21 | Under 11 | $134K |
| Allopurinol Generic | 20 | 38 | Under 11 | $82.08 |
| Tramadol Hcl Generic | 20 | 20 | Under 11 | $93.41 |
| Cefpodoxime Proxetil Generic | 15 | 15 | Under 11 | $2,357 |
| Ursodiol Generic | 14 | 14 | Under 11 | $1,245 |
| Gabapentin Generic | 13 | 15 | Under 11 | $50.46 |
Brand drugs: 194 claims; generic drugs: 466 claims; opioid claims: 20.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Aji Mathew $1,315 ($1,315 in general payments such as food, travel and fees) from 13 companies. The largest payer was Sobi, Inc with $246.
| Company | Payments | Amount |
|---|---|---|
| Sobi, Inc SOBI.ST | 8 | $246 |
| Syndax Pharmaceuticals, Inc. SNDX | 6 | $236 |
| Astellas Pharma US Inc 4503.T | 6 | $196 |
| Novartis Pharmaceuticals Corporation NVS | 5 | $132 |
| GlaxoSmithKline, LLC. GSK | 4 | $103 |
| AstraZeneca Pharmaceuticals LP AZN | 3 | $98.07 |
| Celgene Corporation BMY | 3 | $72.64 |
| Abbvie Inc. ABBV | 2 | $59.52 |
| Incyte Corporation INCY | 2 | $58.18 |
| Taiho Oncology, Inc. 4578.T | 1 | $35.04 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.